[Form 4] Transcat Inc Insider Trading Activity
Gary J. Haseley, a director of Transcat Inc. (TRNS), reported equity changes arising from restricted stock unit (RSU) activity in September 2025. On September 11, 2025 704 shares were acquired following RSU vesting at no cash cost. Following that transaction, Mr. Haseley held 39,102 shares directly. The filing also shows 1,200 shares held indirectly through family trusts.
Separately, on September 10, 2025 he received an award of 1,587 RSUs granted under a Rule 16b-3 exempt transaction; those RSUs vest on September 10, 2026 and convert one-for-one to common stock when vested. The filing is a routine Section 16 disclosure documenting vesting and a new RSU grant.
- 704 vested shares acquired increased the director's direct stake to 39,102 shares
 - 1,587 RSUs granted align the reporting person with shareholder interests through future vesting
 - Clear one-for-one conversion of RSUs to common stock simplifies dilution/accounting impacts
 
- None.
 
Insights
TL;DR: Routine insider vesting and a new RSU grant modestly increase director alignment with shareholders without cash purchase.
The Form 4 documents a common, non-reciprocal insider event: 704 shares were acquired on vesting and 1,587 RSUs were granted with a one-year vesting schedule. The immediate effect is a small increase in direct ownership to 39,102 shares, plus 1,200 shares indirectly held via family trusts. For investors this is a typical compensation-to-equity conversion that increases the director's stake and aligns incentives over the vesting period. There is no disclosed cash payment and no option exercise that would impact company cash flows.
TL;DR: Governance-wise, the filing reflects standard equity-based compensation and timely SEC disclosure by the reporting person.
The transactions were reported under Section 16: a grant exempt under Rule 16b-3 and subsequent vesting. The grant's one-year vesting term is disclosed and the conversion ratio is one-for-one, which is straightforward. The filing appears complete and signed by an attorney-in-fact, indicating procedural compliance. There are no unusual transfer mechanisms, related-party sales, or dispositions reported that would raise governance flags.